Community pharmacist's perceptions towards the quality of locally manufactured generic medicines: A descriptive study from Malaysia

Journal of Applied Pharmaceutical Science

Volumn 2, Issue 1, 2012, Pages 56-60

  Hassali, Mohamed Azmi ^a   Shafie, Asrul Akmal ^a   Chong, Chee Ping ^a   Saleem, Fahad ^a   Atif, Muhammad ^a   Chua, Ginnie ^a   Haq, Noman Ul ^a  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

Author keywords

Community pharmacist; Generic medicines; Knowledge; Local pharmaceutical companies; Perception

Indexed keywords

EID: 84875889098     PISSN: None     EISSN: 22313354     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. ADHA. (2009). Australian Department of Health and Ageing (ADHA). Schedule of Pharmaceutical Benefits. Effective 1 September 2009-30 September 2009. Available from:
2. Al-Gedadi, N. A., & Hassali, M. A. Pharmacists' views on generic medicines: A review of the literature. Journal of Generic Medicines 2008; 5(3): 209-218.
3. Allenet, B., & Barry, H. Opinion and behaviour of pharmacists towards the substitution of branded drugs by generic drugs: survey of 1,000 French community pharmacists. Pharmacy World and Science 2003; 25(5): 197-202.
4. Andersson, K., Bergstrom, G., Petzold, M. G., & Carlsten, A. Impact of a generic substitution reform on patients' and society's expenditure for pharmaceuticals. Health Policy 2007; 81: 376-384.
5. Chong, C. P., Hassali, M. A., Bahari, M. B., & Shafie, A. A. Evaluating community pharmacists' perceptions of future generic substitution policy implementation: A national survey from Malaysia. Health Policy 2010; 94: 68-75.
6. Chong, C. P., Hassali, M. A., Bahari, M. B., & Shafie, A. A. Exploring community pharmacists' views on generic medicines: a nationwide study from Malaysia. International Journal of Clinical Pharmacy 2011; 33: 124-131.
7. Chong, C. P., Hassali, M. A., Bahari, M. B., & Shafie, A. A. Generic medicines substitution practices among community pharmacists: a nationwide study from Malaysia. Journal of Public Health 2011; 19(1): 81-90.
8. Chong, C. P., March, G., Clark, A., Gilbert, A., Hassali, M. A., & Bahari, M. B. A web-based survey on Australian community pharmacists' perceptions and practices of generic substitution. Journal of Generic Medicines 2010; 7: 342-353.
9. Chong, C. P., March, G., Clark, A., Gilbert, A., Hassali, M. A., & Bahari, M. B. A nationwide study on generic medicines substitution practices of Australian community pharmacists and patient acceptance. Health Policy 2011; 99: 139-148.
10. Eriko, K., Nobunori, S., & Shiro, U. Community pharmacists' perspectives on generic substitution in Japan. Journal of Public Health 2011. Doi: 10.1007/s10389-011-0393-7.
11. Gossell-Williams, M., & Harriott, K. Generic substitution in Jamaica: challenges to improving effectiveness. WHO Drug Information 2007; 21(4): 294-299.
12. Hassali, M. A., Kong, D. C. M., & Stewart, K. Generic medicines: Perceptions of consumers in Melbourne, Australia. International Journal of Pharmacy Practice 2005; 13(4): 257-264.
13. Hassali, M. A., Yuen, K. H., Ibrahim, M. I. M., Wong, J. W., Ng, B. H., & Ho, D. S. S. Malaysian pharmaceutical industry: opportunities & challenges. Journal of Generic Medicines 2009; 6: 246-252.
14. Karim, S. A., Pillai, G., Ziqubu-Page, T. T., Cassimjee, M. H., & Morar, M. S. Potential savings from generic prescribing and generic substitution in South Africa. Health Policy and Planning 1996; 11(2): 198-205.
15. King, D. R., & Kanavos, P. Encouraging the use of generic medicines: implications for transition economies. Croatian Medical Journal 2002; 43(4): 462-469.
16. Kirking, D. M., & Ascione, F. J. Perspectives on generic pharmaceuticals: some conclusions. Journal of The American Pharmaceutical Association 2001; 41(6): 826-828.
17. Kirking, D. M., Gaither, C. A., Ascione, F. J., & Welage, L. S. Pharmacists' individual and organizational views on generic medications. Journal of American Pharmacist Association 2001; 41(5): 723-728.
18. Kjoenniksen, I., & Lindbaek, M. Patients' attitudes towards and experiences of generic drug substitution in Norway. Pharmacy World and Science 2006; 28(5): 284-289.
19. Lofgren, H. Generic drugs: international trends and policy developments in Australia. Australian Health Review 2004; 27(1): 39-48.
20. McGavock, H. Generic substitution: issues relating to the Australian experience. Pharmacoepidemiology and Drug Safety 2001; 10(6): 555-556.
21. MOH. (2000). Ministry of Health Malaysia (MOH). Malaysian Guidelines for the Conduct of Bioavailability and Bioequivalence Studies. Kuala Lumpur: MOH.
22. MOH. (2007). Ministry of Health Malaysia (MOH). National Medicines Policy of Malaysia. Putrajaya: MOH.
23. Mott, D. A., & Cline, R. R. Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution. Med Care 2002; 40(8): 662-674.
24. NPS. (2006). National Prescribing Service (NPS). Generic medicines: same difference? NPSNEWS 44, February 2006. Available from:
25. NPS. (2007a). National Prescribing Service (NPS). Generic medicines: dealing with multiple brands. NPSNEWS 55, December 2007. Available from:
26. NPS. (2007b). National Prescribing Service (NPS). Generic medicines: safe & appropriate use. Inpharmation Special Edition; December 2007. Curtin: NPS.
27. NPS. (2008a). National Prescribing Service (NPS). Generic medicines are an equal choice campaign launch. NPS Media Release; October 20, 2008. Available from:
28. NPS. (2008b). National Prescribing Service (NPS). Generic medicines training kit: safe and appropriate use of generic medicines. Available from:
29. NPS. (2009). National Prescribing Service (NPS). Generic medicines: Information for health professionals. Available from:
30. Raynu, T., & Agnes, V. Consumers' perception of generic medicines in community pharmacies in Malaysia. Southern Medical Review 2009; 2(2): 20-23.
31. Segal, R., Wantz, D., & Brusadin, R. Pharmacists' decision making in the selection of generic pharmaceuticals. Journal of Pharmaceutical Marketing and Management 1989; 4(1): 75-91.
32. Suh, D. C. Trends of generic substitution in community pharmacies. Pharmacy World and Science 1999; 21(6): 260-265.
33. USFDA. (2009). U.S. Food and Drug Administration (US FDA). Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book). Available from:
34. WHO. (1997). Quality assurance of pharmaceuticals:A compendium of guidelines and related materials:Volume 1. Geneva: World Health Organization.